UFT plus cisplatin in advanced non-small-cell lung cancer: Interim analysis of 67 patients

ONCOLOGY

Volumn 11, Issue 9 SUPPL. 10, 1997, Pages 103-105

  Ichinose, Yukito ^a  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; UFT;

ADENOCARCINOMA; ADULT; AGED; ALOPECIA; ANEMIA; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; SQUAMOUS CELL CARCINOMA; STOMATITIS; SURVIVAL TIME; THROMBOCYTOPENIA; VOMITING;

AGED; ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DRUG COMBINATIONS; FEMALE; HUMANS; LEUKOPENIA; LUNG NEOPLASMS; MALE; MIDDLE AGED; TEGAFUR; THROMBOCYTOPENIA; URACIL; VOMITING;

EID: 0030822966     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (4)

1. Ichinose Y, Takanashi N, Yano T, et al: A phase II trial of oral tegafur and uracil plus cisplatin in patients with inoperable non-small-cell lung cancer. Cancer 75:2677-2680, 1995.
2. Comis RL, Friedland DM: New chemotherapy agents in the treatment of advanced non-small-cell lung cancer. Lung Cancer 12:63s-99s, 1995.
3. Mountain CF: A new international staging system for lung cancer. Chest 89:225s-233s, 1986.
4. World Health Organization: WHO Hand-book for Reporting Results of Cancer Treatment. WHO Offset Publ. No. 48. Geneva, Switzerland, World Health Organization, 1979.